Array Biopharma Phase 3 MILO study evaluating binimetinib in ovarian cancer enrolling globally
5/15/2014
Array BioPharma Inc. continues recruitment for its ongoing Phase 3 clinical study in patients with low-grade serous ovarian cancer (LGSOC).
Cancer Council Australia welcomes new bowel cancer screening and medical research investment
5/15/2014
At least 35,000 Australian bowel cancer deaths will be prevented thanks to a $95.9 million, four-year plan to finalise Australia's National Bowel Cancer Screening Program in the 2014-15 budget.
New research identifies potential cause of septic shock
5/15/2014
A fundamental new understanding indicates that a toxic by- product of the body's own metabolism leads to septic shock.
Chemo-radiosensitivity enhanced by autophagic activation with nimotuzumab
5/15/2014
A study published in the May 2014 issue of Experimental Biology and Medicine was aimed at determining whether an EGFR-targeted therapy combined with chemo-radiotherapy can improve local tumor control...
New, high-tech device developed for transferring DNA into cells
5/15/2014
The ability to transfer a gene or DNA sequence from one animal into the genome of another plays a critical role in a wide range of medical research - including cancer, Alzheimer's disease, and...
Researchers find Novel target for chemotherapy-resistant leukemia cells
5/15/2014
Researchers at Children's Hospital Los Angeles have discovered that by targeting a particular receptor, chemotherapy-resistant cancer cells can be killed in an acute form of childhood leukemia...
Link discovered between colon cancer and metabolism
5/15/2014
More than 60 years ago Otto Warburg recognized that cancer cells differ from normal cells in the metabolic pathway they use for the oxidation of sugar.
There is increasing interest in using the body's own immune system to attack tumour cells - a strategy that can be very effective without the side effects associated with conventional chemotherapy.
Successful surgery to treat rare bone cancer allows professional surfer to return to the water
5/15/2014
When professional surfer Richie Lovett began experiencing hip pain at 31, he attributed it to his athletic lifestyle.
Powerful T cells target tumors
5/15/2014
Deadly skin cancers in mice shrank in response to a new treatment that may complement other "immunotherapies" developed recently to boost the body's own defenses against disease threats, according to...